Key Dates

Related Announcements

• October 10, 2024 - NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed). See NOFO RFA-CA-24-035.

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application webinar on Tuesday, November 12, 2024 from 3:00 P.M. - 4:00 P.M. (EST) for the RFA-CA-24-035 entitled “NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)". NCI staff members involved in this Notice of Funding Opportunity will provide orientation and technical assistance to potential applicants by explaining the goals and objectives of the National Clinical Trials Network (NCTN) Network Group Integrated Translational Science Centers and answering questions from attendees about the NCTN Program. Potential applicants are encouraged to submit their questions to [email protected] in advance of the teleconference. Slides will be available at: https://ctep.cancer.gov/initiativesPrograms/nctn.htm two days following the completion of this webinar.

To join the webinar, follow the link below:

https://cbiit.webex.com/cbiit/j.php?MTID=m93f68a479d271389534f8cfed697022c

Meeting number: 2315 474 7178

Meeting password: tKcPMVk3*35 

Audio for the webinar may be accessed by phoning: 1-650-479-3207

Meeting access number: 2315 474 7178

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-24-035.

Inquiries

Please direct all inquiries to:

Margaret Mooney, M.D.
National Cancer Institute (NCI)
Telephone: 240-276-6006 
Email: [email protected]